Advisory
Pharmacy M&A advisory for Canada's owners, buyers, and partners
Not every situation needs a full brokerage mandate. Sometimes you need a pharmacist who has done deals to look at one specific problem: the structure, the financing, the diligence file, or the number a partner will not agree to.
Describe your situationWhere we help
Six situations we advise on
Deal structuring: asset vs share
The structure decision can move your after-tax proceeds by six figures. We model both paths with your accountant, including the lifetime capital gains exemption of $1,275,000 as of 2026.
Financing strategy
How much bank debt the deal can carry at a 1.25x DSCR, where vendor take-back fits, and how to package the file so a credit committee says yes the first time.
Due diligence support
Buying without a broker? We review the target the way an owner would: normalized EBITDA, payer mix, rebate dependence, lease, staffing, and the questions the seller hopes you will not ask.
Succession and exit planning
Owners who plan 12 to 24 months ahead sell for more. We build the roadmap: what to fix, when to start, and what your pharmacy needs to look like on the day it goes to market.
Valuation disputes and partner buyouts
When partners disagree on value, a pharmacist-built valuation with documented adjustments gives both sides a credible number to negotiate from.
Turnaround advisory
A distressed or underperforming pharmacy is not always a selling problem, sometimes it is an operations problem. We diagnose which one you have and what it is costing you in eventual sale value.
The right fit
When advisory fits, and when brokerage does
Advisory fits when you have a specific question or a deal already in motion: a buyer at your door, a purchase you found yourself, a partnership that needs a number, or a bank that needs a better package. You keep running the transaction; we bring the pharmacy deal expertise.
Full brokerage fits when you want the whole process managed: valuation, confidential marketing, buyer qualification, negotiation, and everything through closing. If you are selling and do not have a buyer, start with sell a pharmacy. If you are searching, start with buy a pharmacy.
Fees
Scoped, quoted, then started
Advisory work is priced by scope and complexity, quoted before we begin. A single-pharmacy due diligence review, a partner buyout valuation, and a multi-year succession plan are different jobs and are priced as such. No retainers that bill for effort instead of answers.
If an advisory engagement grows into a full sale or purchase mandate, we credit the relationship honestly and move to a success fee structure, so you are never paying twice for the same work.
Read before you decide
The thinking behind our advice is public. Start with these guides.
Asset sale vs share sale
Why buyers and sellers want different structures, and how the gap gets priced.
Bank requirements for pharmacy financing
DSCR, loan-to-value, and what credit committees actually look for.
Pharmacy valuation in Canada
The complete guide to multiples, normalization, and what moves value.